Perhaps a Pyrrhic victory

OXFORD - Chiroscience Group plc (LSE:CRO) may have earned a Pyrrhic victory last week when Sweden's Medical Products Agency granted regulatory approval for Chirocaine, CRO's levobupivacaine long-acting local anaesthetic.

The registration opens the door to approval throughout Europe. Unfortunately, plans to launch the product look to be held up by the